ERBB2 and breast carcinoma: In this sense, a novel, shortened splice variant of this transcription factor (EGR4-S) was recently found in breast cancer tissue, which showed an altered cell signalling pathway of the human epidermal growth factor receptor 2 (HER2) pathway, but not in normal breast tissue [49].